Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?

BACKGROUND: Epidemiologic studies have suggested that hypertriglyceridemia and insulin resistance are related to the development of colon cancer. Nuclear peroxisome proliferator-activated receptors (PPAR), which play a central role in lipid and glucose metabolism, had been hypothesized as being invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenenbaum, Alexander, Boyko, Valentina, Fisman, Enrique Z, Goldenberg, Ilan, Adler, Yehuda, Feinberg, Micha S, Motro, Michael, Tanne, David, Shemesh, Joseph, Schwammenthal, Ehud, Behar, Solomon
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440374/
https://www.ncbi.nlm.nih.gov/pubmed/18565233
http://dx.doi.org/10.1186/1475-2840-7-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440374/
https://www.ncbi.nlm.nih.gov/pubmed/18565233
http://dx.doi.org/10.1186/1475-2840-7-18

Ejemplares similares